Wells Fargo
IART icon

Wells Fargo’s Integra LifeSciences IART Stock Holding History

Wells Fargo’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,000
Closed -$16K – 6515
2020
Q1 		$16K Buy
+1,000
New +$52.5K ﹤0.01% 5649

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Wells Fargo's IART Position: Q2 2026 in Review

Wells Fargo increased its Integra LifeSciences (IART) stake by 96% in Q2 2026, buying an estimated $434K and bringing the position to 63,358 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #4010.

Wells Fargo first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $179M in Q4 2016. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Wells Fargo held 63,358 shares of Integra LifeSciences worth $1.14M as of Q2 2026.
  • Wells Fargo bought 30,998 Integra LifeSciences shares in Q2 2026, an estimated $434K.
  • Integra LifeSciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4010 holding.
  • Wells Fargo first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's Integra LifeSciences position peaked at $179M in Q4 2016.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.